BusinessEmergent Keeps Lindahl on 2026 Annual Report After CFO HandoffBy Helena WardOct 17, 2026, 5:07 AM UTC
BusinessEmergent BioSolutions Reports First Quarter 2018 Financial ResultsBy Nasdaq OMXMay 3, 2018, 8:30 PM UTC
BusinessEmergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European CountriesBy Nasdaq OMXApr 12, 2018, 10:30 AM UTC
BusinessEmergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 GuidanceBy Nasdaq OMXNov 2, 2017, 8:15 PM UTC
BusinessEmergent BioSolutions to Release Third Quarter and Nine Months 2017 Financial Results and Conduct a Conference Call on November 2, 2017By Nasdaq OMXOct 19, 2017, 11:00 AM UTC
BusinessEmergent BioSolutions Announces Closing of New $200 Million Senior Secured Credit FacilityBy Nasdaq OMXOct 2, 2017, 11:00 AM UTC
BusinessEmergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 GuidanceBy Nasdaq OMXAug 3, 2017, 8:15 PM UTC
BusinessEmergent BioSolutions to Release Second Quarter 2017 Financial Results and Conduct a Conference Call on August 3, 2017By Nasdaq OMXJul 20, 2017, 11:00 AM UTC
